Cats Reveal Genetic Secrets That Could Help Cure Cancer

Research has unveiled that household cats may play a significant role in understanding and ultimately curing cancer. A groundbreaking study involving nearly 500 pet cats across five countries has identified genetic changes in various feline cancers that could inform treatment strategies for both animals and humans. The research highlights striking similarities between feline and human cancers, particularly in the case of mammary tumors.

The study, which included contributions from the Wellcome Sanger Institute in the United Kingdom and Ontario Veterinary College in Canada, analyzed tumor samples from almost 500 cats to explore the genetic factors associated with cancer. The findings revealed that the mechanisms underlying cancer development in cats mirror those observed in humans. For instance, the research identified parallels between feline mammary carcinomas and human breast cancers, suggesting shared environmental and genetic risk factors.

According to Professor Geoffrey Wood, a lead researcher at Ontario Veterinary College, “Our household pets share the same spaces as us, meaning that they are also exposed to the same environmental factors that we are.” This insight provides a valuable perspective on how external influences may contribute to cancer development in both species.

Approximately one in five Irish households now owns a cat, and cancer ranks among the leading causes of illness and death in this species. The study encompassed 13 different types of feline cancer, examining around 1,000 human cancer-associated genes in both tumor and healthy tissue samples. The comparative analysis facilitated a deeper understanding of the genetic alterations driving cancer in cats and how they align with those in humans and dogs.

The researchers identified seven driver genes linked to cancer development when mutated, which could lead to innovative breast cancer treatments for humans. Similar genetic changes were noted in a range of tumors, including those affecting blood, bone, lung, skin, gastrointestinal, and central nervous systems.

Bailey Francis, co-first author at the Wellcome Sanger Institute, emphasized the importance of cross-species cancer genomics: “By comparing cancer genomics across different species, we gain a greater understanding of what causes cancer.” This collaborative approach benefits both veterinary and human medical fields, fostering shared knowledge.

Dr. Louise Van Der Weyden, senior author at the Wellcome Sanger Institute, described the study as a pivotal advancement in feline oncology. “This is one of the biggest ever developments in feline oncology,” she stated. “The genetics of domestic cat tumors are no longer a ‘black box.’ We can now begin to take the next steps toward precision feline oncology, ultimately catching up with the diagnostic and therapeutic options available for dogs and, someday, humans.”

These groundbreaking findings were published in the journal Science, marking a significant step forward in understanding the genetic underpinnings of cancer across species. Future research will likely explore these genetic changes further, paving the way for new therapeutic approaches that could benefit both cats and humans in their battle against cancer.